ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Rheumatology

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,319Medicare Part D Prescriptions Filled, Including Refills

Rank: 10 out of 416

$3.97M Total Retail Price of All Prescriptions

Rank: 1 out of 416

836 Patients Receiving at Least One Drug in Part D
75%Patients 65 Years and Older
91% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

12% of this provider’s 836 patients filled at least one prescription for a schedule three drug, compared to an average of 12%.

Risky Drugs to Seniors

1% of this provider’s 7,338 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

64% of this provider’s prescriptions were for brand-name drugs, compared to an average of 27%.

Prescription Price

$351 was the average price of a prescription from this provider, compared to $166 among peers.

Prescriptions per Patient

14 is the average number of prescriptions (including refills) per patient, compared to an average of 10.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
CELEBREX 1,285 941 10 1 11
LYRICA 1,161 713 10 2 20
LIDODERM 1,040 874 3 19
METHOTREXATE 764 440 4 2
VOLTAREN 575 453 5 22
FLECTOR 516 460 10 6 82
HYDROCODONE-ACETAMINOPHEN 500 211 S3 7 4
TRAMADOL HCL 435 286 8 7
ENBREL 385 237 10 9 8
HUMIRA 360 194 10 10 15
SAVELLA 349 237 10 11 78
MELOXICAM 303 228 12 9
CYMBALTA 287 184 13 17
AMITRIPTYLINE HCL 206 73 R 14 43
OMEPRAZOLE 191 110 15 10
HYDROXYCHLOROQUINE SULFATE 188 96 16 3
ALENDRONATE SODIUM 169 114 17 5
PENNSAID 152 123 18 124
PREDNISONE 144 58 19 1
DICLOFENAC SODIUM 140 76 20 32
CIMZIA 122 72 10 21 96
GABAPENTIN 113 75 22 6
ACETAMINOPHEN-CODEINE 110 90 S3 23 45
IBUPROFEN 108 61 24 24
SIMPONI 89 51 10 25 99
ISONIAZID 83 54 26 225
LEFLUNOMIDE 73 34 27 12
ACTONEL 64 62 28 40
DEXILANT 59 28 29 73
MYCOPHENOLATE MOFETIL 57 14 30 94
SULINDAC 55 53 31 98
NAPROXEN 54 33 32 34
PROLIA 53 47 33 97
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Jan. 11, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.